Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Ranitidine hydrochloride |
Is a |
False |
Ranitidine (substance) |
Inferred relationship |
Some |
|
Ranitidine measurement |
Component |
True |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |
Ranitidine poisoning |
Causative agent (attribute) |
True |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |
Accidental ranitidine poisoning |
Causative agent (attribute) |
False |
Ranitidine (substance) |
Inferred relationship |
Some |
|
Intentional ranitidine poisoning |
Causative agent (attribute) |
False |
Ranitidine (substance) |
Inferred relationship |
Some |
|
intoxication par la ranitidine d'intention indéterminée |
Causative agent (attribute) |
False |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |
Ranitidine adverse reaction |
Causative agent (attribute) |
True |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |
Allergy to ranitidine (finding) |
Causative agent (attribute) |
False |
Ranitidine (substance) |
Inferred relationship |
Some |
|
Ranitidine overdose |
Causative agent (attribute) |
True |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |
Accidental ranitidine overdose |
Causative agent (attribute) |
True |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |
Intentional ranitidine overdose |
Causative agent (attribute) |
True |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |
surdose de ranitidine d'intention indéterminée |
Causative agent (attribute) |
False |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ranitidine (as ranitidine hydrochloride) 150 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ranitidine (substance) |
Inferred relationship |
Some |
|
Ranitidine (as ranitidine hydrochloride) 300 mg effervescent oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ranitidine (substance) |
Inferred relationship |
Some |
|
Ranitidine 75mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ranitidine (substance) |
Inferred relationship |
Some |
|
Product containing precisely ranitidine (as ranitidine hydrochloride) 150 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ranitidine (substance) |
Inferred relationship |
Some |
|
Product containing precisely ranitidine (as ranitidine hydrochloride) 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ranitidine (substance) |
Inferred relationship |
Some |
|
ranitidine 25 mg/mL, ampoule de 2 mL d'une solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ranitidine (substance) |
Inferred relationship |
Some |
|
Ranitidine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |
Product containing ranitidine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |
Ranitidine (as ranitidine hydrochloride) 75 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ranitidine (substance) |
Inferred relationship |
Some |
|
Alcohol + ranitidine hydrochloride 7.5%vv/16.8mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ranitidine (substance) |
Inferred relationship |
Some |
|
Ranitidine bismuth citrate (substance) |
Is a |
False |
Ranitidine (substance) |
Inferred relationship |
Some |
|
Product containing ranitidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |
Ranitidine hydrochloride 25mg/mL injection solution 6mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ranitidine (substance) |
Inferred relationship |
Some |
|
Ranitidine hydrochloride 50mg/50mL intravenous injection solution premixed 50mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ranitidine (substance) |
Inferred relationship |
Some |
|
Ranitidine hydrochloride 25mg/mL injection solution 40mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ranitidine (substance) |
Inferred relationship |
Some |
|
Ranitidine hydrochloride 25mg/mL injection solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ranitidine (substance) |
Inferred relationship |
Some |
|
Ranitidine (as ranitidine hydrochloride) 75 mg effervescent oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ranitidine (substance) |
Inferred relationship |
Some |
|
Product containing precisely ranitidine (as ranitidine hydrochloride) 25 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ranitidine (substance) |
Inferred relationship |
Some |
|
Accidental ranitidine poisoning |
Causative agent (attribute) |
True |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |
Intentional ranitidine poisoning |
Causative agent (attribute) |
True |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |
Allergy to ranitidine (finding) |
Causative agent (attribute) |
True |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ranitidine (as ranitidine hydrochloride) 150 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ranitidine (as ranitidine hydrochloride) 300 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |
Ranitidine (as ranitidine hydrochloride) 75 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |
Ranitidine bismuth citrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Ranitidine (substance) |
Inferred relationship |
Some |
|
Ranitidine hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Ranitidine (substance) |
Inferred relationship |
Some |
|
Product containing precisely ranitidine (as ranitidine hydrochloride) 150 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |
Ranitidine (as ranitidine hydrochloride) 300 mg effervescent oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ranitidine (as ranitidine hydrochloride) 15 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ranitidine (as ranitidine hydrochloride) 50 milligram/2 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |
Ranitidine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |
Product containing only ranitidine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |
Product containing only ranitidine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ranitidine (as ranitidine hydrochloride) 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |
Ranitidine (as ranitidine hydrochloride) 75 mg effervescent oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ranitidine (as ranitidine hydrochloride) 25 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |
Ranitidine (as ranitidine hydrochloride) 25 mg/mL solution for infusion and/or injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ranitidine (substance) |
Inferred relationship |
Some |
1 |